Kilitch Drugs (India) Limited (BOM:524500)
India · Delayed Price · Currency is INR 180.10
+8.55 (4.98%)
At close: Sep 4, 2026
Kilitch Drugs (India) Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 6,297 | 4,459 | 5,813 | 6,270 | 2,175 | 2,613 | |
Market Cap Growth | 10.44% | -23.29% | -7.29% | 188.33% | -16.79% | 108.08% |
Enterprise Value | 6,468 | 4,411 | 5,540 | 6,029 | 1,821 | 2,325 |
Last Close Price | 180.10 | 127.55 | 176.86 | 190.75 | 68.28 | 82.06 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 20.72 | 14.78 | 21.77 | 42.94 | 20.81 | 35.47 |
PS Ratio | 2.65 | 1.89 | 2.93 | 4.06 | 1.56 | 2.29 |
PB Ratio | 2.27 | 1.61 | 2.90 | 3.57 | 1.44 | 1.86 |
P/TBV Ratio | 2.41 | 1.70 | 3.17 | 4.01 | 1.66 | 2.22 |
P/OCF Ratio | 26.28 | 18.61 | 33.14 | - | 84.09 | 45.19 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.73 | 1.87 | 2.79 | 3.91 | 1.30 | 2.04 |
EV/EBITDA Ratio | 17.76 | 11.96 | 17.70 | 24.41 | 10.38 | 19.99 |
EV/EBIT Ratio | 19.20 | 12.87 | 18.97 | 27.03 | 12.26 | 23.21 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.32 | 0.32 | 0.25 | 0.18 | 0.15 | 0.15 |
Debt / EBITDA Ratio | 2.44 | 2.41 | 1.58 | 1.28 | 1.26 | 1.76 |
Net Debt / Equity Ratio | 0.07 | 0.07 | -0.05 | -0.21 | -0.25 | -0.26 |
Net Debt / EBITDA Ratio | 0.55 | 0.54 | -0.32 | -1.51 | -2.11 | -3.17 |
Net Debt / FCF Ratio | - | -0.26 | 0.34 | 4.69 | 30.16 | 15.24 |
Asset Turnover | - | 0.61 | 0.72 | 0.67 | 0.65 | 0.55 |
Inventory Turnover | - | 7.55 | 7.76 | 19.88 | 19.60 | 15.19 |
Quick Ratio | - | 1.55 | 1.71 | 2.06 | 1.65 | 1.43 |
Current Ratio | - | 1.83 | 2.06 | 2.27 | 1.84 | 1.65 |
Return on Equity (ROE) | - | 12.36% | 13.26% | 8.32% | 5.70% | 4.61% |
Return on Assets (ROA) | - | 5.56% | 6.60% | 6.07% | 4.32% | 3.03% |
Return on Invested Capital (ROIC) | 8.48% | 10.73% | 12.85% | 12.42% | 9.44% | 6.51% |
Return on Capital Employed (ROCE) | - | 10.20% | 12.80% | 12.70% | 9.90% | 7.10% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.77% | 6.77% | 4.59% | 2.33% | 4.81% | 2.82% |
FCF Yield | -12.00% | -16.94% | -5.05% | -1.27% | -0.56% | -0.93% |
Buyback Yield / Dilution | -7.55% | -110.43% | 49.52% | -2.23% | -0.10% | -0.56% |
Total Shareholder Return | -7.55% | -110.43% | 49.52% | -2.23% | -0.10% | -0.56% |